Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial. (2019)
Attributed to:
Alpha-1-antitrypsin (AT) deficiency and the serpinopathies: pathobiology and new therapeutic strategies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(19)30190-0
PubMed Identifier: 31281061
Publication URI: http://europepmc.org/abstract/MED/31281061
Type: Journal Article/Review
Volume: 7
Parent Publication: The Lancet. Respiratory medicine
Issue: 9
ISSN: 2213-2600